Pre-publication history
Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study
- Equal contributors
BMC Cancer 2012, 12:547 doi:10.1186/1471-2407-12-547
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 12 Jan 2012 | |
| Reviewer's Report | Yasunari Nakamoto | 03 May 2012 | |
| Reviewer's Report | George Chen | 12 May 2012 | |
| Reviewer's Report | Ren-Shyan Liu | 26 May 2012 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 26 Sep 2012 |
| Reviewer's Report | Yasunari Nakamoto | 17 Oct 2012 | |
| Editorial acceptance | 07 Nov 2012 | ||
| Published | 23 Nov 2012 |

